Prevalence of Foxp3 positive T regulatory cells is increased during progression of cutaneous squamous tumors

Yonsei Medical Journal

Volumn 49, Issue 6, 2008, Pages 942-948

  Jang, Tae Jung ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

Forkhead box p3; Skin tumor; T regulatory cells

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BOWEN DISEASE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SKIN CARCINOMA; TISSUE LEVEL;

BOWEN'S DISEASE; CARCINOMA, SQUAMOUS CELL; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; KERATOSIS, ACTINIC; SKIN NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 58149468819     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.6.942     Document Type: Article

References (40)

1. Urbach F. Ultraviolet radiation and skin cancer of humans. J Photochem Photobiol B 1997;40:3-7.
2. Beissert S, Loser K. Molecular and cellular mechanisms of photocarcinogenesis. Photochem Photobiol 2008;84: 29-34.
3. Simon JC, Hara H, Denfeld RW, Martin S. UVB-irradiated dendritic cells induce nonproliferating, regulatory type T cells. Skin Pharmacol Appl Skin Physiol 2002;15:330-4.
4. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002;23:445-9.
5. Enk AH. Dendritic cells in tolerance induction. Immunol Lett 2005;99:8-11.
6. Loser K, Mehling A, Loeser S, Apelt J, Kuhn A, Grabbe S, et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 2006;12:1372-9.
7. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood 2003;101:4862-9.
8. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001;193:1285-94.
9. Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, et al. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 2001;98:2736-44.
10. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-64.
11. + regulatory T cells. Nat Immunol 2003;4:330-6.
12. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-61.
13. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001;27:68-73.
14. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000;106:R75-81.
15. + T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999;163:5211-8.
16. Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 2001;61:4766-72.
17. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002;169:2756-61.
18. Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 2005;65:2457-64.
19. Mizukami Y, Kono K, Kawaguchi Y, Akaike H, Kamimura K, Sugai H, et al. Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br J Cancer 2008;98:148-53.
20. Hiraoka N, Onozato K, Kosuge T, Hirohashi S. Prevalence of Foxp3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 2006;12: 5423-34.
21. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6:345-52.
22. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005;6:338-44.
23. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005;6:331-7.
24. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 2005;22:329-41.
25. Chen ML, Pittet MJ, Gorelik L, Flavell RA. Weissleder R, von Boehmer H, et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-bata signals in vivo. Proc Natl Acad Sci U S A 2005;102: 419-24.
26. + T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999;163:5211-8.
27. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res 1999;59:3128-33.
28. + regulatory T cells in wild-type hosts. Proc Natl Acad Sci U S A 2005; 102:9253-7.
29. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-9.
30. Alvaro T, Lejeune M, Salvado MT, Bosch R, García JF, Jaén J, et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005;11:1467-73.
31. + T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 2007;13:2075-81.
32. Loddenkemper C, Schernus M, Noutsias M, Stein H, Thiel E, Nagorsen D. In situ anlaysis of FOXP3+ egulatory T cells in human colorectal cancer. J Transl Med 2006;4:52.
33. Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, Roncador G, et al. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 2006;108:2957-64.
34. Nagorsen D, Voigt S, Berg E, Stein H, Thiel E, Loddenkemper C. Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Transl Med 2007;5:62.
35. Rutella S, Lemoli RM. Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications. Immunol Lett 2004;94:11-26.
36. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol 2004;172:4676-80.
37. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 2000;30:1538-43.
38. + T cells and dendritic cells in vivo. J Exp Med 2006;203:505-11.
39. Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, Serra P, et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006;7:83-92.
40. + regulatory T cells: role of B7-H3 expression and antigen presentation. Eur J Immunol 2007;37:2117-26.